Clinical Trial Update: A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of ADXS11-001 or MEDI4736 alone or in combination for cervical cancer or HPV-associated head and neck cancer was terminated; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Cancer
• Hpv-associated Cancer

Drugs mentioned

• ADXS11-001
• MEDI4736 (Durvalumab)

Snippet

Sponsor: Advaxis, Inc. | Conditions: Cervical Cancer, Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-03-20